Growth Metrics

Fulgent Genetics (FLGT) Other Non-Current Liabilities (2016 - 2025)

Fulgent Genetics (FLGT) has disclosed Other Non-Current Liabilities for 9 consecutive years, with $7.3 million as the latest value for Q4 2025.

  • Quarterly Other Non-Current Liabilities rose 59.61% to $7.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.3 million through Dec 2025, up 59.61% year-over-year, with the annual reading at $7.3 million for FY2025, 59.61% up from the prior year.
  • Other Non-Current Liabilities hit $7.3 million in Q4 2025 for Fulgent Genetics, up from $2.0 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $16.6 million in Q2 2023 to a low of $182000.0 in Q2 2025.
  • Historically, Other Non-Current Liabilities has averaged $6.7 million across 5 years, with a median of $6.3 million in 2021.
  • Biggest five-year swings in Other Non-Current Liabilities: skyrocketed 1792.01% in 2022 and later crashed 98.74% in 2025.
  • Year by year, Other Non-Current Liabilities stood at $6.8 million in 2021, then soared by 44.54% to $9.8 million in 2022, then surged by 53.36% to $15.1 million in 2023, then tumbled by 69.75% to $4.6 million in 2024, then skyrocketed by 59.61% to $7.3 million in 2025.
  • Business Quant data shows Other Non-Current Liabilities for FLGT at $7.3 million in Q4 2025, $2.0 million in Q3 2025, and $182000.0 in Q2 2025.